|Bid||13.15 x 1000|
|Ask||13.16 x 800|
|Day's Range||12.06 - 13.37|
|52 Week Range||10.70 - 28.82|
|PE Ratio (TTM)||N/A|
|YTD Daily Total Return||-9.17%|
|Beta (5Y Monthly)||-4.32|
|Expense Ratio (net)||1.11%|
The new coronavirus from China has claimed more than 800 lives and there are now more than 37,000 documented cases of the respiratory illness worldwide, making it more deadly than the 2003 SARS epidemic. ...
Volatility and uncertainty has resulted in a strong demand for leveraged and inverse-leveraged ETFs as these could fetch outsized returns on quick market turns in a short span.
The indices are well off the early lows Tuesday afternoon, but the question is whether they will manage another strong finish. The automatic buying of any dips smacks of compliancy, but in the age of algorithms, patterns tend to repeat much longer than they have in the past. In the 'old' days, the conventional wisdom was that when a pattern becomes common knowledge, it tended to stop working as traders anticipated it and undermined the movement.
Leveraged biotechnology exchange traded funds (ETFs) are known to make big moves, but sometimes those moves are not always about price action. What Happened Entering Monday, the Direxion Daily S&P Biotech ...